Toxoplasmosis in pregnant women in Guayaquil: Risk Factors and associated social Determinants of Health
DOI:
https://doi.org/10.70099/BJ/2025.02.03.17Palabras clave:
gestational toxoplasmosis, risk marker, social determinants, congenital infection, EcuadorResumen
Toxoplasmosis is a zoonosis caused by the parasite Toxoplasma gondii; it has a complex life cycle, with a sexual phase in cats and an asexual phase in warm-blooded hosts, including humans. This research was conducted to determine the risk factors and social determinants of health in pregnant women diagnosed with toxoplasmosis at two health centers in Guayaquil, Ecuador. It was a descriptive, field-based, non-experimental, cross-sectional, and prospective study. It was developed using data collected through self-administered surveys in 2024. The 18-24 age group predominated (45.64%). Pregnant women between 13 and 24 weeks of gestation stood out (38.93%). They lived with cats (12.75%), cleaned the cat litter box without protection (23.48%), and came from rural areas (65.10%). Although 64.43% were aware of the disease and 52.35% knew how it was transmitted, a statistically significant association (p < 0.05) was found between infection and variables such as contact with cats and ethnicity. These results highlight the need to strengthen prevention strategies considering social and environmental factors, especially in warm urban contexts such as Guayaquil, where conditions favor the persistence of the parasite.
Citas
1. Barzgar G, Ahmadpour E, Kohansal MH, Mehrani-Moghaddam S, Jafari Koshki T, Barac A, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women. J Infect Dev Ctries. 2024; 18(1):60–65. doi: https://doi.org/10.3855/jidc.17832
2. Espinoza-Rojas J, López-Mora E, Dabanch-Peña J, Cruz-Choappa R. Recomendaciones para el diagnóstico y tratamiento de la infección por Toxoplasma gondii. Rev Chil Infectol. 2022; 39(2):132-137. doi: http://dx.doi.org/10.4067/S0716-10182022000200132
3. Guerrero A, Núñez D, Benítez G, Alfonso O, Portillo C, Romero J, et al. Toxoplasmosis en el embarazo: características epidemiológicas, clínicas y laboratoriales en un centro de referencia. Rev Inst Med Trop. 2023;18(1):12-20. Available from: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S1996-36962023000100012&lng
4. García-González S. Revisión bibliográfica: asociación entre Toxoplasma gondii y las enfermedades psiquiátricas. Trabajo de fin de grado, Universidade da Coruña, La Coruña-España, 2023. Available from: https://ruc.udc.es/dspace/bitstream/handle/2183/33372/GarciaGonzalez_Senda_TFG_2023.pdf?sequence=2
5. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2): 264 - 296. doi: https://doi.org/10.1128/CMR.05013-11
6. Wong-Chung YY, Castro-Jalca J. Toxoplasmosis congénita: epidemiología, manifestaciones clínicas y diagnóstico de laboratorio. MQRInvestigar. 2023;7(2):1350-1372. doi: https://doi.org/10.56048/MQR20225.7.2.2023.1350-1372
7. Fernández RT, Acosta MY, Montaño AM. Toxoplasmosis congénita: reporte de casos. Rev Med UCSG. 2013;17(3):192-197. Available from: https://editorial.ucsg.edu.ec/ojs-medicina/index.php/ucsg-medicina/article/view/556
8. Urbina-Fuentes M, González-Block MA. La importancia de los determinantes sociales de la salud en las políticas públicas. 1st ed. Cuernavaca: Instituto Nacional de Salud Pública; 2012. p. 132. Available from: https://www.insp.mx/images/stories/Produccion/pdf/131209_determinantesSociales.pdf
9. Fernández RT, Montaño AM, Basantes SP, Ponce JP. Estudio seroepidemiológico para estimar el riesgo de infección congénita por Toxoplasma gondii en Guayaquil, Ecuador. Rev Patol Trop. 2014;43(2): 182-194. doi: https://doi.org/10.5216/rpt.v43i2.31131
10. Salari N, Rahimi A, Zarei H, Abdolmaleki A, Rasoulpoor S, Shohaimi S, et al. Global seroprevalence of Toxoplasma gondii in pregnant women: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025;25(1):90. doi: https://doi.org/10.1186/s12884-025-07182-2
11. Zavala-Hoppe AN, Olmedo-Vera CS, Saavedra-Peña GF, Tamayo-Navarro KR. Epidemiología y factores de riesgo de toxoplasmosis en los países de Latinoamérica. BIOSANA. 2024; 4(4):328-339. doi: https://doi.org/10.62305/biosana.v4i4.239
12. Mulu-Gelaw Y, Worku-Dagnew G, Degu-Alene G, Gangneux JP, Robert-Gangneux F. Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2024;18(5):e0012198. doi: https://doi.org/10.1371/journal.pntd.0012198
13. Velasco-Velásquez S, Orozco A, Ramírez M, Pachón L, Hurtado-Gomez MJ, Valois G, et al. Impact of education on knowledge, attitudes, and practices for gestational toxoplasmosis. J Infect Public Health. 2024;17(9):102516. doi: https://doi.org/10.1016/j.jiph.2024.102516
14. Mareze M, Benitez AdN, Brandão APD, Pinto-Ferreira F, Miura AC, Martins FDC, et al. Socioeconomic vulnerability associated to Toxoplasma gondii exposure in southern Brazil. PLoS One. 2019;14(2):e0212375. doi: https://doi.org/10.1371/journal.pone.0212375
15. Benitez AdN, Martins FDC, Mareze M, Santos NJR, Ferreira FP, Martins CM, et al. Correction: Spatial and simultaneous representative seroprevalence of anti-Toxoplasma gondii antibodies in owners and their domiciled dogs in a major city of southern Brazil. PLOS ONE. 2018; 13(2): e0192570. doi: https://doi.org/10.1371/journal.pone.0180906
16. Melo MS, Freitas LRS, Lima-Júnior FEF, Vargas A, Pereira JDS, Brito-Júnior PA, et al. Spatial pattern of congenital toxoplasmosis incidence and its relationship with vulnerability and national health indicators in Brazil. Spat Spatiotemporal Epidemiol. 2024; 51:100693. doi: https://doi.org/10.1016/j.sste.2024.100693
17. Carmo EL, Morais R, Oliveira A, Figueredo J, Figueredo M, Silva A, et al. Soroepidemiologia da infecção pelo Toxoplasma gondii no Município de Novo Repartimento, Estado do Pará, Brasil. Rev Pan-Amaz Saude. 2016; 7(4):79–87. doi: http://dx.doi.org/10.5123/s2176-62232016000400010
18. Bracho-Mora AM, Tumbaco-Bailón NN, Ormaza-Anchundia JI, Rivero-Rodríguez Z, Véliz-Zevallos I. Factores de riesgo para la infección por Toxoplasma gondii en embarazadas que asisten al Centro de Salud tipo C, Manta, Ecuador. QhaliKay. 2022; 6(2):28-38. Available from: https://revistas.utm.edu.ec/index.php/QhaliKay/article/view/4438
19. Cedeño-Quevedo P, Sarango-Borja M, Suconota-Pintado A. Toxoplasmosis en embarazadas en el centro de salud Puerto Bolívar perspectiva enfermería Machala-Ecuador . Pol Con. 2023 ;8(4): 1498-1514. Available from: https://polodelconocimiento.com/ojs/index.php/es/article/view/5513/13612
20. Velásquez-Serra GC, Piloso-Urgiles LI, Guerrero-Cabredo BP, Chico-Caballero MJ, Zambrano-Zambrano SL, Yaguar-Gutierrez EM, et al. Current Situation of Congenital Toxoplasmosis in Ecuador. J Community Health. 2020;45(1):170-175. doi: https://doi.org/10.1007/s10900-019-00729-3
21. Pimienta CI, Prado Q, Jhofre V, Ramírez LR, Pérez C. Prevalencia de Toxoplasma gondii en mujeres embarazadas asintomáticas en Quito, Ecuador 2020. Bol. malariol. salud ambient. 2021; 61(3): 436-442. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1401435
22. Flores-Gilces FF & Armijos-Briones FM. Toxoplasma Gondii y factores de riesgo en adolescentes en estado de gestación que acuden al laboratorio clínico integral FERFA. MQRInvestigar. 2024; 8(1):4233-4252. doi: https://doi.org/10.56048/MQR20225.8.1.2024.4233-4252
23. Exposito-Lara A, Rodriguez-Moldon Y, Díaz-Armas MT. Factores asociados a la seroprevalencia de toxoplasmosis. RCuR. 2024;26(1): e1271. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=9451438
24. Sánchez-Artigas R, Barba-Maggi MA, Ramos-Campi YC, Brossard-Peña E. Some epidemiological variables associated to toxoplasmosis in women of childbearing age from Riobamba. Rev Cubana Invest Bioméd. 2020; 39(1): e348. Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/348
25. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Oréfice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis. 2003;9(1):55-62. doi: https://doi.org/10.3201/eid0901.020160
26. Condori-Sarzuri V, Cruz-Ochoa JN, Loza-Murguia MG. Toxoplasmosis ocular. Una visión general durante el embarazo. Curr.Opin.Nurs.Res. 2020; 2(2): 26-38. doi: https://doi.org/10.69753/j.conr.2020.2.2.26-38
27. Chávez-Arévalo MA, Roa-Correa ST, Terraza-Cadavid JA, García-Cuan A. Nivel de conocimiento sobre toxoplasmosis en mujeres gestantes que asisten a consulta prenatal. Biociencias. 2022; 17(2):15-24. doi: https://doi.org/10.18041/2390-0512/biociencias.2.10690
28. Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg. 2014;90(5):794-799. doi: https://doi.org/10.4269/ajtmh.13-0722
29. Cortés JA, Gómez JE, Silva PI, Arévalo L, Arévalo-Rodrígez I, Alvarez MI, et al. Guía de atención integral para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto y puerperio: sección toxoplasmosis en el embarazo. Infectio. 2012;16(4):230–246. doi: https://doi.org/10.1016/S0123-9392(12)70018-8
30. Durlach R, Freuler C, Messina M, Freilij H, González-Ayala S, Venturini MC, et al. Consenso argentino de toxoplasmosis congénita 2020. Medicina. 2021 ;81(2):257-268. Available from: https://www.medicinabuenosaires.com/revistas/vol81-21/n2/257.pdf
31. Smith N, Goulart C, Hayward J, Kupz A, Miller C, Dooren G. Control of human toxoplasmosis. International Journal for Parasitology.2021; 51(2-3):95-121. doi: https://doi.org/10.1016/j.ijpara.2020.11.001
32. Pinto-Ferreira F, Caldart ET, Pasquali AK, Mitsuka-Breganó R, Freire RL, Navarro IT. Patterns of Transmission and Sources of Infection in Outbreaks of Human Toxoplasmosis. Emerg Infect Dis. 2019; 25(12):2177-2182. doi: https://doi.org/10.3201/eid2512.181565
33. Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital Toxoplasmosis: The State of the Art. Front. Pediatr. 2022; 10:894573. doi: https://doi.org/10.3389/fped.2022.894573
34. Cruz-Quevedo M, Hernández-Cruz A, Dorta-Contreras AJ. El nexo entre biología, respuesta inmune y clínica en la infección por Toxoplasma gondii. Rev Cubana Invest Bioméd. 2019;38(4): e256. Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/256
35. Campo-Portacio DM, Guerrero-Velásquez LF, Castillo-García AP, Orozco-Méndez K, Blanco-Tuirán PJ. Detección de Toxoplasma gondii en agua para el consumo humano proveniente de jagüeyes del área rural del municipio de Sincelejo. Biomédica. 2021;41(Supl. 1): 82-99. doi: https://doi.org/10.7705/biomedica.5858
36. Kassie E, Kebede N, Kassa T, Garoma A, Girma M, Asnake Y, et al. Seroprevalence and risk factors for Toxoplasma gondii infection among pregnant women at Debre Markos Referral Hospital, northwest Ethiopia. Trans R Soc Trop Med Hyg. 2024;118(1):61-68. doi: https://doi.org/10.1093/trstmh/trad053
37. Cárdenas-Sierra D, Domínguez-Julio G, Blanco-Oliveros M, Soto JA, Tórres-Morales E. Seroprevalencia y factores de riesgo asociados a toxoplasmosis gestacional en el Nororiente Colombiano. Rev Cuid. 2023 ;14(1):e2287. doi: http://dx.doi.org/10.15649/cuidarte.2287
38. İnci A, Sohel MH, Babür C, Uslu S, Karademir GK, Yürük M, et al. Overview of One Health Concept Focusing on Toxoplasmosis. Turkiye Parazitol Derg. 2023;47(4):256-274. doi: https://doi.org/10.4274/tpd.galenos.2023.38039
39. Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein P, et al. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. EcoHealth. 2019;16 (1): 378–390. doi: https://doi.org/10.1007/s10393-019-01405-7
40. Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour-Shiadeh M, Danesh M, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection. 2020; 26(6): 673-683. doi: https://doi.org/10.1016/j.cmi.2020.01.008
41. Jeannel D, Niel G, Costagliola D, Danis M, Traore BM, Gentilini M. Epidemiology of Toxoplasmosis among Pregnant Women in the Paris Area. Int J Epidemiol. 1988; 17 (3): 595–602. doi: https://doi.org/10.1093/ije/17.3.595
42. Neamah SR, Abdullah YJ. The relationship between ABO and rhesus blood groups with toxoplasmosis in Thi-Qar Province, Iraq. J Chem Health Risks. 2021;11(4):367–373. Available from: https://jchr.org/index.php/JCHR/article/view/141
43. Flegr J, Preiss M, Klose J, Rottenberg ME. Toxoplasmosis-associated difference in intelligence and personality in men depends on their Rhesus blood group but not ABO blood group. PLoS One. 2013;8(4):e61272. doi: https://doi.org/10.1371/journal.pone.0061272
44. Magboul AM, Elamin E, Tamomh AG, Mohammed HY, Suliman MA, Ibrahim RM, et al. Toxoplasma gondii Infection and ABO Blood Group Association Among Pregnant Sudanese Women: A Case Study. Int J Womens Health. 2023;15:1375-1381. doi: https://doi.org/10.2147/IJWH.S419740
45. Hosseini SA, Amouei A, Sharif M, Sarvi SH, Galal L, Javidnia J, et al. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples. Epidemiology and Infection. 2019; 147:e36. doi: https://doi.org/10.1017/S0950268818002947
46. Gavilán-Cabrera T, Fernández de Chilavert J, Trujillo Y, Wolke S. Percepción acerca de la toxoplasmosis en mujeres de 18 a 35 años de la ciudad de Luque. RCUPAP. 2023; 3(1):43-48. doi: https://doi.org/10.54360/rcupap.v3i1.122
47. Celis-Giraldo D, García-López LL, Valencia-Hernández JD, Acosta-Dávila JA, Vargas-Montes M, Gómez-Marín JE. Conocimientos, actitudes y prácticas sobre toxoplasmosis en dos comunas de Armenia, Quindío, con alta prevalencia de la infección. Rev Fac Nac Salud Pública. 2021; 40(1): e344576. doi: https://doi.org/10.17533/udea.rfnsp.e344576
48. Contiero-Toninato AP. Conhecimento de toxoplasmose entre os profissionais e as (y las) mulheres grávidas nos serviços (embarazadas en los servicios) públicos de saúde. Salud(i)Ciencia. 2019; 23(4):1-2. Available from: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1667-89902019000100006&lng=es
49. Rosa-Junior W, Bezerra FF, Do Carmo-da Silva M, Prado-Quevedo SI. Nivel de conocimiento de infección de toxoplasmosis y factores de riesgos en embarazadas del servicio de ginecología del Hospital Distrital de Itauguá en el 2021. Rev Medicinae Signum. 2022;1(1):65-72. Available from: https://revistas.unc.edu.py/index.php/fmunc/article/view/75/57
50. Araújo EC da S, Castro M. de VM de, Dias-Filho CAA. Relevância clínica do conhecimento acerca da toxoplasmose congênita por parte das gestantes. REAS. 2024; 24(9):e16962. doi: https://doi.org/10.25248/reas.e16962.2024
51. Merizalde-Mora AD, Vásconez-Benavides MN, Burgos-Saona AC, Agurto-Espinoza RV, Encalada-Peñafiel PA, Haro-Baque JJ, et al. Factores Socioeconómicos Asociados a la Presencia de Toxoplasmosis Adultos de 25 a 50 Años del Sector La Pampa, Recinto El Deseo del cantón Milagro, mayo- agosto 2023. SAGA Rev. Cienc. Multidiscip. 2025; 2(2), 480-491. doi: https://doi.org/10.63415/saga.v2i2.127
52. Deganich M, Boudreaux C, Benmerzouga I. Toxoplasmosis Infection during Pregnancy. Trop Med Infect Dis. 2023 ;8(1): 3. doi: https://doi.org/10.3390/tropicalmed8010003
Descargas
Publicado
Cómo citar
Número
Sección
Categorías
Licencia

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors who publish with BioNatura Journal agree to the following terms: Authors retain copyright and grant the BioNatura Institutional Publishing Consortium (BIPC) right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.